Adalimumab biosimilars have similar efficacy to originator adalimumab when treating non-infectious uveitis.

چکیده

To compare the efficacy in achieving and maintaining control of inflammation between adalimumab biosimilars and originator adalimumab as initial biologic treatment among patients with non-infectious uveitis (NIU). This is a multicentre retrospective cohort study. Events of uveitis relapse were…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• یووئیت و التهاب داخل چشمی